News & Perspective

Nov 11, 2019

Nov 11, 2019
MONUSCO Ebola vax

European Commission grants final approval to Merck's Ebola vaccine

In other developments, only 1 new Ebola case has been reported in recent days.

Nov 08, 2019

Nov 08, 2019
boy flu shot

US flu continues slow rise with plenty of flu B activity

Some parts of the south and central US are among the few hot spots, and flu strains vary by region.

Nov 07, 2019

Nov 07, 2019
Ebola vaccination

European regulators consider 2nd Ebola vaccine

With 1 new case today, the outbreak total climbs to 3,286, and recent cases reflect movement of infected people.

Nov 06, 2019

Nov 06, 2019
Ebola response in DR Congo

DRC Ebola cases hit 3,285 as transmission rate slows

Also, a study today highlights serious long-term symptoms among Ebola survivors.

Nov 06, 2019
Camel and handlers

With 3 new Saudi MERS cases, study notes antibodies in Pakistan camel workers

Coincidentally, all 3 new Saudi cases involved camel contact.

Nov 05, 2019

Nov 05, 2019
Older man reading prescription

Older adults concerned about antibiotic overuse—until they get sick

Poll finds 41% expect antibiotics if they have a cold that lingers.

Nov 04, 2019

Nov 04, 2019
Chelsea & Westminster Hospital, West London

Report shows drug-resistant infections climbing in England

About 61,000 antibiotic-resistant infections occurred in England last year, up 9%.

Nov 04, 2019

Johnson & Johnson's Ebola vaccine lands in DRC

11,000 doses of Johnson & Johnson's Ebola vaccine arrived in the DRC over the weekend.

Nov 04, 2019
Injection drug use

Study notes increasing candidemia in injection drug users

The proportion of candidemia in patients with injection drug use more than doubled.

Nov 01, 2019

Nov 01, 2019
Red blood cells and antibodies

Measles does long-term damage to immune system, studies show

After severe measles, children lost a median of 40% of their antibody repertoires.


by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


  Become an underwriter»